aspirin has been researched along with heparitin sulfate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansell, J; Cola, C | 1 |
| Breimer, DD; Cohen, AF; Danhof, M; de Boer, A; Magnani, HN | 1 |
| Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM | 1 |
| Gryglewski, RJ; Swies, J | 1 |
| Abate, G; Brillante, C; Fraccalaglio, L; Palombo, V; Pennese, F; Taormina, F | 1 |
| Geerts, WH; Gent, M; Ginsberg, JS; Hirsh, J; Jay, RM; Leclerc, J; Levine, MN; Neemeh, JA; Powers, PJ; Turpie, AG | 1 |
| Guyotat, D; Mahul, P; Mazet, E; Mismetti, P; Reynaud, J; Tardy, B; Tardy-Poncet, B | 1 |
| Chen, AH; Frangos, SG; Sumpio, B | 1 |
| Boinot, C; Brizard, A; Chamlian, V; Gruel, Y; Guicheteau, M; Macchi, L; Magnin, G; Pourrat, O; Sarfati, R | 1 |
| Adams, HP; Bendixen, B; Clarke, WR; Hansen, MD; Wilterdink, JL; Woolson, RF | 1 |
| Allard, S; Cohen, H; de Swiet, M; Letsky, E; Woo, YL | 1 |
| Bar, J; Blickstein, D; Hod, M | 1 |
| Carman, TL; Farray, D; Fernandez, BB | 1 |
| Giannubilo, SR; Tranquilli, AL | 1 |
| Cheng, H; Huang, X; Lang, T; Li, Y; Liu, Y; Wang, G; Yin, Q; Zheng, Z | 1 |
3 review(s) available for aspirin and heparitin sulfate
| Article | Year |
|---|---|
Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.
Topics: Aspirin; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Epoprostenol; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Iloprost; Necrosis; Platelet Aggregation Inhibitors; Skin; Skin Diseases; Thrombocytopenia; Thrombosis | 1990 |
Vascular drugs in the new millennium.
Topics: Abciximab; Animals; Anistreplase; Antibodies, Monoclonal; Anticoagulants; Aspirin; Chondroitin Sulfates; Clopidogrel; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Immunoglobulin Fab Fragments; Intermittent Claudication; Platelet Aggregation Inhibitors; Streptokinase; Ticlopidine; Vascular Diseases; Venous Thrombosis | 2000 |
The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Brain Diseases; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Postoperative Complications; Venous Thrombosis; Warfarin | 2004 |
5 trial(s) available for aspirin and heparitin sulfate
| Article | Year |
|---|---|
Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers.
Topics: Adult; Aspirin; Blood Coagulation; Chondroitin Sulfates; Dermatan Sulfate; Drug Interactions; Factor Xa Inhibitors; Glycosaminoglycans; Hemostasis; Heparinoids; Heparitin Sulfate; Humans; Male; Platelet Aggregation; Thromboxane B2 | 1991 |
[Comparative study of ASA and heparan sulfate in the secondary prevention of cerebrovascular disorders].
Topics: Aged; Aged, 80 and over; Aspirin; Cerebrovascular Disorders; Female; Fibrinolytic Agents; Follow-Up Studies; Heparitin Sulfate; Humans; Ischemic Attack, Transient; Male | 1993 |
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Heparitin Sulfate; Hip Fractures; Humans; Injections, Subcutaneous; Male; Middle Aged; Postoperative Complications; Thromboembolism | 1996 |
Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Factors; Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Recurrence; Retrospective Studies; Safety; Thrombocytopenia; Treatment Outcome | 1999 |
Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST).
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Chondroitin Sulfates; Confounding Factors, Epidemiologic; Dermatan Sulfate; Drug Administration Schedule; Female; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Severity of Illness Index; Stroke; Survival Rate; Treatment Outcome; United States | 2001 |
7 other study(ies) available for aspirin and heparitin sulfate
| Article | Year |
|---|---|
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K | 1989 |
Streptokinase-prostacyclin--nitric oxide: in vivo interactions.
Topics: Animals; Arginine; Aspirin; Blood Pressure; Cats; Epoprostenol; Extracorporeal Circulation; Fibrinolysis; Heparitin Sulfate; Iloprost; Infusions, Intravenous; Injections, Intravenous; Molsidomine; Nitric Oxide; Nitroarginine; Platelet Aggregation; Streptokinase; Thrombosis; Vasodilator Agents | 1995 |
Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
Topics: Adult; Anticoagulants; Aspirin; Asthma; Cephalosporins; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Risk Factors; Thrombocytopenia; Thromboembolism | 2000 |
Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Antithrombin III; Aspirin; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia; Treatment Outcome | 2002 |
Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
Topics: Adult; Aspirin; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Therapy, Combination; Eczema; Enoxaparin; Female; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications | 2003 |
Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia.
Topics: Anticoagulants; Aspirin; Bone Density; Breast Feeding; Chondroitin Sulfates; Dermatan Sulfate; Female; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infant, Newborn; Polysaccharides; Pregnancy; Pregnancy Complications, Hematologic; Thromboembolism; Thrombophilia; Warfarin | 2012 |
In Vivo Environment-Adaptive Nanocomplex with Tumor Cell-Specific Cytotoxicity Enhances T Cells Infiltration and Improves Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Aspirin; CD8-Positive T-Lymphocytes; Cell Death; Cell Line, Tumor; Docetaxel; Endocytosis; Heparitin Sulfate; Humans; MCF-7 Cells; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Neoplasms; Polyethylene Glycols; Polyethyleneimine; Tissue Distribution | 2019 |